Scientists Question Data Behind an Experimental Alzheimer’s Drug April 18, 2022 Auto Bot alzheimer's disease, Biotechnology and Bioengineering, Clinical Trials, elderly, United States, your-feed-science 0 Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.